Edoxaban Monotherapy Associated with Better Net Clinical Benefit than Edoxaban Plus Single Antiplatelet in Patients with AF and Stable CAD: EPIC-CAD
Key Points: In patients with stable coronary artery disease and atrial fibrillation,…
STEEER-AF: A Structured Educational Program for Clinicians Improved Adherence to Guideline Recommendation in AF
Key Points: Adherence to guideline recommendations for AF management is suboptimal. STEEER-AF,…
IVORY FINALE: Low-Dose IL-2 Reduces Arterial Inflammation after ACS
Key Points: While inflammation is critical to the pathogenesis of atherosclerosis, few…
QUADRO – Quadruple Polypill More Effective In Lowering Blood Pressure Than Taking Three Separate Medications in Resistant Hypertension
Key Points: Treatment of resistant hypertension often involves at least three or…
A Single Combined Measure Of hsCRP, LDL-C, And Lp(A) Predicts Incident CV Events Over 30 Years Among Women’s Health Study Participants
Key Points: While drug trials evaluate the short-term cardiovascular risk associated with…
ASSURE DES: No Difference In Ischemic Events If Aspirin Is Interrupted Or Continued In Patients With DES Undergoing Non-Cardiac Surgery
Key Points: Anti-platelet therapy after coronary drug eluting stent (DES) placement reduces…
Morning vs. evening dosing of blood pressure meds: No differences in outcomes or safety for either community-dwelling adults or frail nursing home residents
Key Points: Blood pressure follows a circadian rhythm, peaking after waking and…
NOTION-3: Revascularization in Patients Undergoing TAVI Associated with Lower Risk of MACE vs Conservative Treatment
Key Points: The NOTION-3 trial found that FFR-guided revascularization with PCI in…
TAVI Superior to Surgical Aortic Valve Replacement in Women: RHEIA Trial
Key Points: The RHEIA trial found that TAVI was superior to surgical…
SWEDEGRAFT Trial: No Advantage of No-Touch vs Conventional Vein Harvesting in Coronary Artery Bypass Surgery
Key Points: The SWEDEGRAFT study is a prospective, binational multicenter, open-label, registry-based…
Transcatheter Mitral-valve Repair Lowers Hospitalization or CV Death vs Medical Therapy Alone in HF with Moderate to Severe MR: RESHAPE-HF2 Trial
Key Points: The Mitral Transcatheter Edge-to-Edge Repair (M-TEER) procedure with the MitraClip…
Continuation of Anticoagulation Non-Inferior to Interruption during TAVI: POPular PAUSE TAVI Trial.
Key Points: Many patients who undergo transcatheter aortic-valve implantation (TAVI) have an…
Pooled Analysis Showed Semaglutide Reduced Combined CV death or Worsening HF and Worsening HF alone but No Significant Effect on CV Death
Key Points: Heart failure with mildly reduced or preserved ejection fraction (hereafter…
Transcatheter Edge-To-Edge Repair Is Non-Inferior To Surgery In Patients With Secondary Mitral Regurgitation: MATTERHORN Trial
Key Points: The MATTERHORN trial found that the transcatheter edge-to-edge repair (TEER)…
T-TEER Significantly Reduced the Severity of Secondary Tricuspid Regurgitation and Improved Quality of Life. TRI-FR Trial
Key Points: The TRI.FR trial found that tricuspid transcatheter edge-to-edge repair (T-TEER)…
ABYSS – Beta Blocker Interruption in Post-Myocardial Infarction Patients
Key Points: In the ABYSS trial, 3700 patients who had a left…
Vitrusiran Reduces Risk of Death and CV Events in Patients with ATTR-CM
Key Points: ATTR amyloid cardiomyopathy, resulting from accumulation of TTR amyloid protein…